Daily Archives: January 18, 2018

Currently, there are no data on the prevalence rate of hepatitis B virus (HBV) serologic markers in patients with newly diagnosed inflammatory bowel disease (IBD) in Korea, which is a hepatitis B endemic area. Continue reading →

Budesonide extended-release tablets (multimatrix [MMX]) are indicated for induction of remission of mild to moderate ulcerative colitis (UC). Budesonide MMX is a second-generation corticosteroid with low systemic bioavailability related to extensive fi… Continue reading →

Vedolizumab (VDZ) is used to treat Crohn’s disease (CD) and ulcerative colitis (UC). Data from large real-world (RW) cohorts can further characterize safety events not fully elucidated in clinical trials. Continue reading →

Non-adherence to medications is common in patients with inflammatory bowel disease (IBD). The aim of this study was to assess adherence to biologic medications prescribed for IBD, and to identify risk factors for biologic non-adherence. Continue reading →

Standard weight-based infliximab (IFX) dosing for inflammatory bowel disease (IBD) results in long-term clinical remission in only 40-60% of patients. Patient and disease factors account for variability in IFX exposure. Achieving optimal IFX exposure a… Continue reading →

Patients hoping to improve their understanding of treatments recommended by their providers frequently turn to the Internet as their source of information. Medical foods are emerging adjunct treatments in Inflammatory Bowel Diseases (IBD) with a growin… Continue reading →

We sought to analyze whether response to second-line biologic varies depending on reason for discontinuation of primary anti-TNF agent (primary non-response [PNR], secondary loss of response [LOR] after initial response, or intolerance), through a syst… Continue reading →

The aim of this study was to investigate the predictors of short- and long-term clinical response to the initial anti-TNFs in moderate to severe ulcerative colitis (UC) patients. Continue reading →

Inflammatory Bowel Disease is a group of chronic and relapsing diseases that can be associated with poor nutrient absorption. Despite the rise in biologics, there are patients unable to maintain remission. Hence there is a rising interest for medical f… Continue reading →

Patients with inflammatory bowel disease (IBD) without adequate access to urgent medical care for exacerbation of symptoms tend to obtain care from emergency departments (ED), which is associated with an increased use of opiates, steroids, and poor pat… Continue reading →